Diaceutics PLC
LSE:DXRX

Watchlist Manager
Diaceutics PLC Logo
Diaceutics PLC
LSE:DXRX
Watchlist
Price: 121.5 GBX Market Closed
Market Cap: 102.6m GBX
Have any thoughts about
Diaceutics PLC?
Write Note

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Diaceutics PLC

Revenue
26.1m GBP
Cost of Revenue
-4.4m GBP
Gross Profit
21.7m GBP
Operating Expenses
-26.2m GBP
Operating Income
-4.4m GBP
Other Expenses
1.6m GBP
Net Income
-2.8m GBP

Margins Comparison
Diaceutics PLC Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
UK
Diaceutics PLC
LSE:DXRX
102.9m GBP
83%
-17%
-11%
US
PerkinElmer Inc
LSE:0KHE
1.4T USD
55%
14%
9%
US
Thermo Fisher Scientific Inc
NYSE:TMO
211.1B USD
41%
17%
14%
US
Danaher Corp
NYSE:DHR
177.5B USD
60%
21%
18%
KR
Samsung Biologics Co Ltd
KRX:207940
71.2T KRW
50%
31%
24%
CH
Lonza Group AG
SIX:LONN
39.5B CHF
29%
13%
9%
US
Agilent Technologies Inc
NYSE:A
39.7B USD
55%
25%
22%
US
IQVIA Holdings Inc
NYSE:IQV
40B USD
35%
14%
9%
US
Mettler-Toledo International Inc
NYSE:MTD
28B USD
59%
28%
21%
US
Illumina Inc
NASDAQ:ILMN
24.3B USD
64%
7%
-36%
US
West Pharmaceutical Services Inc
NYSE:WST
23.5B USD
35%
20%
17%
Country UK
Market Cap 102.9m GBP
Gross Margin
83%
Operating Margin
-17%
Net Margin
-11%
Country US
Market Cap 1.4T USD
Gross Margin
55%
Operating Margin
14%
Net Margin
9%
Country US
Market Cap 211.1B USD
Gross Margin
41%
Operating Margin
17%
Net Margin
14%
Country US
Market Cap 177.5B USD
Gross Margin
60%
Operating Margin
21%
Net Margin
18%
Country KR
Market Cap 71.2T KRW
Gross Margin
50%
Operating Margin
31%
Net Margin
24%
Country CH
Market Cap 39.5B CHF
Gross Margin
29%
Operating Margin
13%
Net Margin
9%
Country US
Market Cap 39.7B USD
Gross Margin
55%
Operating Margin
25%
Net Margin
22%
Country US
Market Cap 40B USD
Gross Margin
35%
Operating Margin
14%
Net Margin
9%
Country US
Market Cap 28B USD
Gross Margin
59%
Operating Margin
28%
Net Margin
21%
Country US
Market Cap 24.3B USD
Gross Margin
64%
Operating Margin
7%
Net Margin
-36%
Country US
Market Cap 23.5B USD
Gross Margin
35%
Operating Margin
20%
Net Margin
17%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Diaceutics PLC Competitors

Country Company Market Cap ROE ROA ROCE ROIC
UK
Diaceutics PLC
LSE:DXRX
102.9m GBP
-7%
-6%
-11%
-12%
US
PerkinElmer Inc
LSE:0KHE
1.4T USD
3%
2%
3%
3%
US
Thermo Fisher Scientific Inc
NYSE:TMO
211.1B USD
13%
6%
9%
7%
US
Danaher Corp
NYSE:DHR
177.5B USD
8%
5%
6%
5%
KR
Samsung Biologics Co Ltd
KRX:207940
71.2T KRW
10%
6%
11%
7%
CH
Lonza Group AG
SIX:LONN
39.5B CHF
6%
3%
6%
5%
US
Agilent Technologies Inc
NYSE:A
39.7B USD
25%
13%
18%
17%
US
IQVIA Holdings Inc
NYSE:IQV
40B USD
22%
5%
11%
9%
US
Mettler-Toledo International Inc
NYSE:MTD
28B USD
-648%
24%
49%
29%
US
Illumina Inc
NASDAQ:ILMN
24.3B USD
-37%
-18%
4%
4%
US
West Pharmaceutical Services Inc
NYSE:WST
23.5B USD
18%
13%
18%
17%
Country UK
Market Cap 102.9m GBP
ROE
-7%
ROA
-6%
ROCE
-11%
ROIC
-12%
Country US
Market Cap 1.4T USD
ROE
3%
ROA
2%
ROCE
3%
ROIC
3%
Country US
Market Cap 211.1B USD
ROE
13%
ROA
6%
ROCE
9%
ROIC
7%
Country US
Market Cap 177.5B USD
ROE
8%
ROA
5%
ROCE
6%
ROIC
5%
Country KR
Market Cap 71.2T KRW
ROE
10%
ROA
6%
ROCE
11%
ROIC
7%
Country CH
Market Cap 39.5B CHF
ROE
6%
ROA
3%
ROCE
6%
ROIC
5%
Country US
Market Cap 39.7B USD
ROE
25%
ROA
13%
ROCE
18%
ROIC
17%
Country US
Market Cap 40B USD
ROE
22%
ROA
5%
ROCE
11%
ROIC
9%
Country US
Market Cap 28B USD
ROE
-648%
ROA
24%
ROCE
49%
ROIC
29%
Country US
Market Cap 24.3B USD
ROE
-37%
ROA
-18%
ROCE
4%
ROIC
4%
Country US
Market Cap 23.5B USD
ROE
18%
ROA
13%
ROCE
18%
ROIC
17%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top